Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Tolerability of Kinetin, a Nutritional Supplement That Corrects the Splicing Defect, in Patients With Familial Dysautonomia

NCT02274051 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT02274051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02274051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Tolerability of Kinetin, a Nutritional Supplement That Corrects the Splicing Defect, in Patients With Familial Dysautonomia
Lead sponsor
NYU Langone Health
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2009
Completion date
May 4, 2019
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

familial dysautonomia